Disclosure Panels Details Page
Testicular Cancer Panel - Disclosures as of 06/06/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Marian Birkeland PhD | None | None | None | None | ✔ |
| David Chism MD, MS | Pfizer Inc. | Exelixis Inc. Karyopharm Therapeutics Inc. |
None | None | ✔ |
| Nicholas Cost MD | None | None | None | None | - |
| Ithaar Derweesh MD | Genentech, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
Genentech, Inc. | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Hamid Emamekhoo MD | Bristol-Myers Squibb Company Janssen Pharmaceutica Products, LP MedImmune Inc. |
Exelixis Inc. | None | None | - |
| Darren Feldman MD | None | UpToDate | None | None | ✔ |
| Daniel Geynisman MD | None | AstraZeneca Pharmaceuticals LP Exelixis Inc. Pfizer Inc. |
None | None | - |
| Timothy Gilligan MD, MS | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Steven Hancock MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Alyse Johnson-Chilla MS | None | None | None | None | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Chad LaGrange MD, FACS | None | None | None | None | ✔ |
| Ellis Levine MD | None | None | None | None | ✔ |
| Daniel Lin MD | GenomeDx Genomic Health, Inc. MDxHealth, Inc |
Astellas Pharma US, Inc. Dendreon Corporation |
None | None | - |
| William Lowrance MD, MPH | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | - |
| Bradley McGregor MD | Bristol-Myers Squibb Company Celldex Therapeutics Exelixis Inc. Seattle Genetics, Inc. |
Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Exelixis Inc. Genentech, Inc. Nektar Therapeutics |
None | None | ✔ |
| Nicole McMillian MS | None | None | None | None | ✔ |
| Paul Monk MD | sanofi-aventis U.S. | None | None | None | ✔ |
| Alicia Morgans MD, MPH | None | AstraZeneca Pharmaceuticals LP Genentech, Inc. Janssen Pharmaceutica Products, LP |
None | None | ✔ |
| Joel Picus MD | None | None | None | None | - |
| Phillip Pierorazio MD | None | None | None | None | ✔ |
| Lenora Pluchino PhD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Edward Rampersaud MD | None | None | None | None | - |
| Philip Saylor MD | None | None | None | None | ✔ |
| Kanishka Sircar MD | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | ✔ |
| David Smith MD | Astellas Pharma US, Inc. Bristol-Myers Squibb Company Eli Lilly and Company Incyte Corporation MedImmune Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation OncoMed Pharmaceuticals Pfizer Inc. Seattle Genetics, Inc. |
Merck & Co., Inc. | None | None | - |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Katherine Tzou MD | None | None | None | None | ✔ |
| Daniel Vaena MD | AstraZeneca Pharmaceuticals LP Bioclin Therapeutics Bristol-Myers Squibb Company Calithera Merck & Co., Inc. Nektar Therapeutics |
AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Caris |
None | None | ✔ |
| Kosj Yamoah MD, PhD | None | None | None | None | ✔ |
| Jonathan Yamzon MD | None | None | None | None | ✔ |
| James Yu MD, MHS | None | Augmenix | None | None | ✔ |